The Institute for Research in Biomedicine was founded in 2000 with the goal of advancing the study of human immunology, with particular emphasis on the mechanisms of host defense.

The IRB benefits from a wide international network of collaborations.

In addition, the IRB provides teaching and training programs for graduate students from Swiss and foreign Universities.

NewsAll news

	11.10.2018 The Good, the Bad and the Neuroprotective – from IRB a computer-designed antibody to cure prions Prion diseases affect the brain, causing neurodegenerative problems that always lead to death. They attracted attention in the late 90s due to the “Mad Cow” scare. Today... Read more
	11.10.2018 IRB collaborates with CERBIOS on developing antibodies targeted at Leukemia Cells The Institute for Research in Biomedicine (IRB-USI, Bellinzona, www.irb.usi.ch) and Cerbios-Pharma SA (Bargengo, Lugano), a company active in developing and producing... Read more
	11.10.2018 New paper from the Cejka lab published in Nature Communications When DNA gets broken, cells can utilize two main repair pathways. The first mechanism simply patches the two broken ends together at the cost of mutations in the... Read more
	08.10.2018 New paper from the Cavalli Lab Pyruvate (PYR) dehydrogenase complex (PDC) is an enzymatic system that plays a crucial role in cellular metabolism as it controls the entry of carbon into the Krebs... Read more
	22.09.2018 Marie Heim-Vögtlin Prize 2018 to Sara Montagner Dr. Sara Montagner received the Marie Heim-Vögtlin Prize 2018 from the Swiss National Science Foundation (SNSF) for her research on the function of immune cells... Read more